Company Filing History:
Years Active: 2022-2024
Title: George Scott Pesiridis: Innovator in STING Agonist Research
Introduction
George Scott Pesiridis is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of medical research, particularly in the development of treatments for various disease states, including cancer. With a total of 2 patents to his name, Pesiridis continues to push the boundaries of innovation in his field.
Latest Patents
Pesiridis's latest patents include "Methods for administering STING agonists" and "Modulators of stimulator of interferon genes (STING)." The first patent relates to methods of treating disease states in humans by systemically administering a STING agonist or a pharmaceutically acceptable salt thereof. The second patent discloses compounds with specific formulas that can be used as modulators of STING, which are crucial in the treatment of various diseases.
Career Highlights
George Scott Pesiridis is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he applies his expertise in pharmaceutical development. His work focuses on innovative approaches to enhance therapeutic outcomes for patients suffering from serious health conditions.
Collaborations
Pesiridis collaborates with esteemed colleagues, including Joshi M Ramanjulu and Jean-Luc Tran, who contribute to the advancement of research in their respective areas. Their combined efforts foster a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
George Scott Pesiridis exemplifies the spirit of innovation in the medical research field. His contributions through patents and collaborations highlight his commitment to improving health outcomes for patients.